N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients

Figure 5

Risk model from m6A-related lncRNAs. (a) LASSO Cox regression analysis of m6A-related lncRNAs. (b, c) Overall survival analysis for patients in high/low risk of train/test set. (d, e) The ROC curve of risk score of train/test set. (f, g) The distributions of risk scores, alive/dead status of train/test set.

(a)

(b)

(c)

(d)

(e)

(f)

(g)